BENJAMIN VANDERSOMMEN: Open Payments
NPI 1376315598 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $529 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $368 |
| ABBVIE INC. | 9 | $189 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Astellas Pharma US Inc | 3 | $73 |
| Exact Sciences Corporation | 2 | $60 |
| PFIZER INC. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Amgen Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
Products named: BREZTRI, PENMENVY, QULIPTA, FARXIGA, Veozah, MAVYRET, The Cologuard Plus Collection Kit, Kerendia.
Industry payments across AZ — which companies pay providers there.
